Sign in

MVIS on Nasdaq

MicroVision, Inc.

Logo: microvision.com4

MicroVision, Inc. is an American electronic components company based in Redmond, founded in 1993.1 Its shares trade on Nasdaq under the symbol MVIS.1

Price unavailable

Last updated Oct 21, 2026.

Overview

1993Founded1

Compare with Neonode, Lynch Group Holdings Limited or Ostin Technology Group Co., Ltd., or pick any stock.

  • TickerMVIS on Nasdaq1
  • IndustryElectronic Components, NEC1
  • HeadquartersRedmond1
  • Websitewww.microvision.com
  • Legal formpublic company1
  • Incorporated inDE5
  • Business address18390 Ne 68Th Street, Redmond, Wa 980525
  • Filer categoryNon-accelerated filer, Smaller reporting company5
  • LEI5299001A8NIHHA9KOY433
  • StatusActive3
  • LEI statusLapsed (not renewed)3
  • Registered addressc/o THE COMPANY CORPORATION, 251 LITTLE FALLS DRIVE, 19808 Wilmington, United States3
  • Registered withDivision of Corporations, Department of State, 9498463

See how the biggest companies compare on our leaderboards

Inc. is defining the next generation of lidar-based perception solutions for automotive, industrial, and security & defense markets.7 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

-1435.4%Gross margin8
-6856.6%Operating margin8
-7862.7%Net margin8
-74.3%Revenue growth, 20258
-171.0%Return on equity8
0.35×Debt to equity8
-$59.4MFree cash flow8

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Business segments

Product Revenue brought in 50% of the revenue MicroVision, Inc. broke down this way in fiscal 2025.

  1. Product Revenue$610.0K850%down 85% from 2024
  2. License and Royalty Revenue$550.0K846%up 16% from 2024
  3. Contract Revenue$48.0K84%down 54% from 2024
Business segments by year
Business segments202320242025
Product Revenue$1.0M$4.1M$610.0K
License and Royalty Revenue$4.9M$475.0K$550.0K
Contract Revenue$1.4M$104.0K$48.0K

Regions

DEMember brought in 78% of the revenue MicroVision, Inc. broke down this way in fiscal 2025.

  1. DEMember$945.0K878%down 74% from 2024
  2. United States$260.0K822%down 75% from 2024
  3. Other Foreign Countries$3.0K80%down 70% from 2024
Regions by year
Regions202320242025
DEMember$2.1M$3.6M$945.0K
United States$4.6M$1.1M$260.0K
Other Foreign Countries$494.0K$10.0K$3.0K

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Cost of revenue24¢$18.5M
  • Research and development41¢$31.7M
  • Selling, general and admin26¢$20.3M
  • Interest9¢$7.3M
  • Income tax0¢$84.0K

Out of $1.2M in revenue.8 The company lost money this year.

Financial statements

Revenue91011128$1.2M in 2025−86% since 2019
0$2.5M$5.0M$7.5M$10.0M2019: $8.9M$8.9M20192020: $3.1M$3.1M2020−65%2021: $2.5M$2.5M2021−19%2022: $664.0K$664.0K2022−73%2023: $7.3M$7.3M2023+993%2024: $4.7M$4.7M2024−35%2025: $1.2M$1.2M2025−74%
Gross profit91011128-$17.3M in 2025
-$20.0M-$10.0M0$10.0M2019: $322.0K$322.0K20192020: $1.7M$1.7M2020+425%2021: $2.5M$2.5M2021+48%2022: $564.0K$564.0K2022−77%2023: $4.5M$4.5M2023+696%2024: -$2.8M-$2.8M20242025: -$17.3M-$17.3M2025+512%
Operating income91011128-$82.8M in 2025+213% since 2019
-$100.0M-$75.0M-$50.0M-$25.0M02019: -$26.5M-$26.5M20192020: -$13.6M-$13.6M2020−49%2021: -$43.9M-$43.9M2021+222%2022: -$53.9M-$53.9M2022+23%2023: -$88.9M-$88.9M2023+65%2024: -$85.5M-$85.5M2024−4%2025: -$82.8M-$82.8M2025−3%
Net income91011128-$95.0M in 2025+259% since 2019
-$100.0M-$75.0M-$50.0M-$25.0M02019: -$26.5M-$26.5M20192020: -$13.6M-$13.6M2020−49%2021: -$43.2M-$43.2M2021+217%2022: -$53.1M-$53.1M2022+23%2023: -$82.8M-$82.8M2023+56%2024: -$96.9M-$96.9M2024+17%2025: -$95.0M-$95.0M2025−2%

Every line of the income statement as filed: the last 3 fiscal years, latest first.8

Period ending2025-12-312024-12-312023-12-31
Revenue$1.2M$4.7M$7.3M
Cost of revenue$18.5M$7.5M$2.8M
Gross (loss) profit-$17.3M-$2.8M$4.5M
Research and development expense$31.7M$49.0M$56.7M
Sales, marketing, general and administrative expense$20.3M$29.3M$36.7M
Impairment loss on intangible assets$10.1M$4.2M
Impairment loss on operating lease right-of-use assets$1.2M
Impairment loss on property and equipment, net$2.2M
Loss (gain) on disposal of fixed assets$143.0K-$34.0K
Total operating expenses$65.5M$82.7M$93.4M
Loss from operations-$82.8M-$85.5M-$88.9M
Bargain purchase gain, net of tax$1.7M
Interest expense-$18.5M-$4.5M-$80.0K
Unrealized gain (loss) on derivative liability$5.7M-$8.9M
Unrealized gain on warrant liability$4.4M
Realized loss on debt extinguishment-$4.7M
Other income$817.0K$2.4M$5.6M
Net loss before taxes-$95.1M-$96.4M-$81.7M
Income tax benefit (expense)$84.0K-$507.0K-$1.1M
Net loss-$95.0M-$96.9M-$82.8M
Net loss per share, basic-$0.35-$0.46-$0.45
Net loss per share - diluted-$0.35-$0.46-$0.45
Weighted-average shares outstanding - basic273.1M shares209.5M shares182.8M shares
Weighted-average shares outstanding - diluted273.1M shares209.5M shares182.8M shares

Compare MicroVision, Inc. with another company

Corporate structure

MicroVision, Inc. sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of MicroVision, Inc.

  • Johannes Gnauck Filed SCHEDULE 13G on MicroVision, Inc., latest Sep 18, 2026
  • BlackRock Filed SCHEDULE 13G/A on MicroVision, Inc., latest Jul 29, 2026 (7 filings since Feb 4, 2022)
  • VANGUARD GROUP INC Filed SCHEDULE 13G/A on MicroVision, Inc., latest Mar 27, 2026 (4 filings since Feb 10, 2022)
  • State Street Corporation Filed SCHEDULE 13G on MicroVision, Inc., latest Nov 10, 2025 (2 filings since Aug 11, 2025)
  • MicroVision, Inc. Redmond, Washington, United States

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What MicroVision, Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$26.1M8 Dec 31, 2025$27.3M8 Dec 31, 2024−4.2%
Accumulated depreciation$21.9M8 Dec 31, 2025$20.2M8 Dec 31, 2024+8.1%
Property and equipment, net$4.3M8 Dec 31, 2025$7.1M8 Dec 31, 2024−39.4%
Operating-lease assets (leased space)$14.1M8 Dec 31, 2025$16.7M8 Dec 31, 2024−16.0%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$32.4M8 Dec 31, 2025$54.5M8 Dec 31, 2024−40.6%
Marketable securities, current$42.5M8 Dec 31, 2025$20.2M12 Dec 31, 2024+110.4%
Debt securities available for sale$20.2M12 Dec 31, 2024$28.6M12 Dec 31, 2023−29.3%

Intangibles and goodwill

ItemLatestA year beforeChange
Intangible assets, net (excluding goodwill)$32.0K8 Dec 31, 2025$11.0M8 Dec 31, 2024−99.7%
Finite-lived intangibles, gross$16.0M8 Dec 31, 2025$20.2M8 Dec 31, 2024−20.5%
Accumulated amortization-$5.9M8 Dec 31, 2025-$5.0M8 Dec 31, 2024−18.3%
Finite-lived intangibles, net$32.0K8 Dec 31, 2025$11.0M8 Dec 31, 2024−99.7%

Inventory

ItemLatestA year beforeChange
Inventory, total$745.0K8 Dec 31, 2025$2.3M8 Dec 31, 2024−67.5%
Raw materials$1.6M8 Dec 31, 2024$1.6M12 Dec 31, 2023+2.7%
Finished goods$745.0K8 Dec 31, 2025$678.0K8 Dec 31, 2024+9.9%

Properties, in its own words

In September 2021, we entered into a lease on approximately 16,681 square feet of space located in Redmond, Washington that we use primarily for product testing and lab space. The lease provides for an initial term of 128 months that commenced November 1, 2021.

In September 2021, we entered into a second lease on approximately 36,062 square feet of space located in Redmond, Washington that we use primarily for general office space. The lease provides for an initial term of 120 months and commenced on December 1, 2022.

The rest of Item 2

In December 2023, we entered into a lease on approximately 60,000 square feet of space located in Hamburg, Germany that we use primarily for general office space and product testing. The lease provides for an initial term of 60 months and commenced on November 1, 2024.

In September 2025, we entered into a lease on approximately 253 acres of space located in Warrenton, Virginia that we use for drone flight testing. The lease provides for an initial term of 12 months and commenced on October 1, 2025.

We believe that our facilities are adequate to meet our needs for the immediate future, and that, should it be needed, suitable additional or substitute space will be available to accommodate any such expansion of our operations. For a further description of our leased properties, see Part II, Item 8, Note 11. Leases, of the notes to our consolidated financial statements, which is incorporated by reference in response to this item.

Item 2 of the 10-K filed Mar 4, 2026.7

Leadership

Who has led MicroVision, Inc., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Richard F. Rutkowski2004
  2. Alexander Y. Tokman2006–2017
  3. Perry Mulligan2017–2019
  4. Sumit Sharma2020–2026
  5. Glen W. Devos2026–now

President

  1. Stephen R. Willey2004–2006
  2. Alexander Y. Tokman2005–2017

Chief financial officer

  1. Richard A. Raisig2004
  2. Jeff T. Wilson2006–2012
  3. Stephen Patrick Holt2013–2021
  4. Anubhav Verma2021–2025
  5. Stephen Hrynewich2025–2026
  6. Christine Chambers2026–now

Chief operating officer

  1. Alexander Y. Tokman2005
  2. Sumit Sharma2019
1995200020052010201520202025
Board members and other officers (44)

Subsidiaries and ownership

Subsidiaries (Exhibit 21)

  • MicroVision GmbH Germany6

The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.

Former names

  • MICROVISION INCDec 30, 1996 to Jun 4, 20155

Timeline

  1. Oct 7, 20268-K Regulation FD disclosure70
  2. Aug 31, 20268-K Other events71
  3. Aug 17, 20268-K Entered a material agreement; Other events72
  4. Aug 10, 20268-K Executive or director change73
  5. Aug 6, 20268-K Results of operations74
  6. Jul 22, 20268-K Change to shareholders' rights; Bylaws or fiscal year changed75
  7. Jul 13, 20268-K Shareholder vote76
  8. Jul 7, 20268-K Regulation FD disclosure77
  9. Jun 25, 20268-K Regulation FD disclosure78
  10. Jun 12, 20268-K Entered a material agreement; Listing notice or transfer; Regulation FD disclosure79
  11. Jun 10, 20268-K Regulation FD disclosure80
  12. Jun 1, 20268-K Other events81
  13. Mar 16, 2026New chief executive Glen W. Devos becomes CEO16
  14. Jun 8, 2020New chief executive Sumit Sharma becomes CEO17
  15. Nov 15, 2017New chief executive Perry Mulligan becomes CEO18
  16. Apr 28, 2006New chief executive Alexander Y. Tokman becomes CEO19
  17. Aug 26, 2004New chief executive Richard F. Rutkowski becomes CEO20
  18. 1993Founded Founded1

Calendar

Coming up

  1. Oct 28, 2026 · After the closeReports results for the quarter ending Sep/202682

When it reported results

  1. Aug 6, 2026Reported quarterly or annual results74
  2. May 13, 2026Reported quarterly or annual results83
  3. Mar 4, 2026Reported quarterly or annual results84
  4. Nov 12, 2025Reported quarterly or annual results85
  5. Aug 7, 2025Reported quarterly or annual results86
  6. May 12, 2025Reported quarterly or annual results87
  7. Mar 26, 2025Reported quarterly or annual results88
  8. Nov 7, 2024Reported quarterly or annual results89

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

368 filings to the SEC since October 2021: 6 annual reports, 15 quarterly reports, 75 major events, 196 insider forms, 14 large holders, 62 other. The latest 20:

  1. Oct 7, 20268-K EDGAR
  2. Oct 2, 20264 EDGAR
  3. Sep 18, 2026SCHEDULE 13G EDGAR
  4. Sep 4, 20264 EDGAR
  5. Sep 4, 20264 EDGAR
  6. Sep 4, 20263 EDGAR
  7. Sep 3, 2026S-8 EDGAR
  8. Sep 2, 20264 EDGAR
  9. Sep 2, 20264 EDGAR
  10. Sep 2, 20264 EDGAR
  11. Sep 2, 20264 EDGAR
  12. Sep 2, 20264 EDGAR
  13. Aug 31, 20268-K EDGAR
  14. Aug 17, 20268-K EDGAR
  15. Aug 17, 2026424B5 EDGAR
  16. Aug 14, 20263 EDGAR
  17. Aug 14, 2026424B5 EDGAR
  18. Aug 10, 20268-K EDGAR
  19. Aug 6, 202610-Q EDGAR
  20. Aug 6, 20268-K EDGAR

The 368 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

3 open-market trades by officers, directors and large owners since October 2021: 0 buys and 3 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Jan 28, 2025Smith JadaDirectorSale20,113$1.61$32.4KForm 4
Dec 17, 2021oz seval FDirectorSale1,250$5.94$7.4KForm 4
Dec 9, 2021BIDDISCOMBE SIMONDirectorSale30,000$6.89$206.6KForm 4

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Executive pay

What the company paid its top executives, from the summary compensation table in its proxy statement. Total pay includes salary, bonus, stock and option awards and other pay, as the company valued them.

YearExecutiveAgeSalaryTotal pay
2025Glen DeVos$347.0K$3.4M94
2025Sumit Sharma$397.5K$1.7M94
2025Drew G. Markham$400.0K$1.5M94
2025Simon Biddiscombe$122.5K$532.7K94
2025Anubhav Verma$411.7K94
2024Former ChiefExecutive Officer$530.0K$6.5M94
2024Former Chief Financial Officer$417.7K$1.1M94
2024SVPGeneral Counsel, Head of People Operations$391.8K$1.0M94
2024Executive Vice ChairDirector$91.2K$179.7K94
2023Former ChiefExecutive Officer$462.9K$4.8M94
2023Former Chief Financial Officer$400.0K$620.0K94
2023SVPGeneral Counsel, Head of People Operations$372.0K$586.8K94
2023Executive Vice ChairDirector$90.0K$231.4K94

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
O'ROURKE & COMPANY, Inc90,219$29.5K0.0%New
Quinn Opportunity Partners LLC20,000$6.5K0.0%New
Strategic Wealth Partners, Ltd.875$2860.0%New
Hollencrest Capital Management100$330.0%New

13F reports cover disclosed long positions in U.S. stocks only.

SEC filer profile

How MicroVision, Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARMICROVISION, INC.2
  • CIK0000065770
  • Employer ID (EIN)91-16008227
  • Filer statusNon-accelerated filer not an emerging growth company; a smaller reporting company; a shell company7
  • Incorporated inDelaware7
  • Fiscal year endsDecember 312
  • Industry code (SIC)3679 Electronic Components, NEC2
  • SEC reviewing officeOffice of Manufacturing, Division of Corporation Finance2
  • Business address18390 Ne 68Th Street, Redmond, WA 980522
  • Phone425-936-68472
  • Shares outstanding23,788,425 as of Aug 3, 202614
  • Public float$313.8M as of Jun 30, 20257
  • AuditorBaker Tilly US, LLP, Seattle, Washington PCAOB ID 23; no auditor attestation of internal control over financial reporting7
  • On EDGAR sinceAug 14, 19962
  • Filings1,437 in all: 4 (481), 8-K (286), 10-Q (83), 424B5 (53), 424B3 (45), 3 (39), DEF 14A (35), S-3 (34)2
    All 58 form types

    SC 13G/A (34), DEFA14A (32), 10-K (28), CORRESP (22), EFFECT (21), S-8 (21), UPLOAD (21), SC 13G (18), ARS (14), POS AM (13), SD (13), PRE 14A (12), 10-K/A (11), S-3/A (11), 10QSB (7), 4/A (7), 424B2 (7), FWP (7), REGDEX (7), SC TO-I/A (7), S-8 POS (6), 8-K/A (5), 10QSB/A (3), D (3), NT 10-K (3), S-1 (3), S-1/A (3), S-3ASR (3), S-3MEF (3), SCHEDULE 13G (3), SCHEDULE 13G/A (3), 10KSB (2), 15-12G (2), 25-NSE (2), 424B4 (2), 5 (2), 8-A12G (2), NT 10-Q (2), RW (2), SB-2/A (2), SC 13D (2), SC TO-I (2), 10-Q/A (1), 10KSB/A (1), 8-A12B (1), CERTNAS (1), DEFR14A (1), DRS (1), POSASR (1), REGDEX/A (1)

  • Latest filingsAnnual report (10-K) Mar 4, 2026
    Quarterly report (10-Q) Aug 6, 2026
    Proxy statement (DEF 14A) Jun 11, 2026
    Latest 8-K (8-K) Oct 7, 2026

Securities registered for trading

ClassSymbolExchange
Common Stock, $0.001 par value per shareMVISThe Nasdaq Stock Market LLC

From the cover page of the 10-K filed Mar 4, 2026 (Section 12(b) of the Exchange Act).7

Risk factors and legal proceedings

The risks MicroVision, Inc. names in Item 1A of its 10-K filed Mar 4, 2026: 34 risks under these headings, as written.7

  • We have a history of operating losses and expect to incur significant losses in the future.
  • We will require additional capital to fund our operations at the level necessary to implement our business plan. Raising additional capital will dilute the value of current shareholders’ investment in us. Additionally, we may be unable to raise capital at the level we expect or on terms acceptable to us.
  • Risks Related to our Financial Statements and Results
  • Our revenue is generated from a small number of customers, and as we have experienced recently and in the past, losing a significant customer negatively impacts our revenue.
  • We have, in the past, identified a material weakness in our internal controls.
  • Our stock price has fluctuated in the past, has recently been volatile and may be volatile in the future, and as a result, investors in our common stock could incur substantial losses.
  • If we are unable to maintain our listing on The Nasdaq Global Market, it could become more difficult to sell our stock in the public market.
  • Our lack of significant financial resources may limit our revenues, potential profits, overall market share, or value.
  • Risks Related to Fundraising Transactions and the Convertible Note
  • Our stockholders will experience further dilution if we issue additional equity securities in future fundraising transactions.
  • Sales of shares of our common stock by the holder of the February 2026 convertible note may cause our stock price to decline.
  • We do not currently intend to pay dividends on our common stock, and any return to investors is expected to come, if at all, only from potential increases in the price of our common stock.
The other 24 risks
  • There are risks associated with our outstanding convertible note that could adversely affect our business and financial condition.
  • Our obligations to the holder pursuant to the February 2026 convertible notes are secured by a security interest in all of our bank and securities accounts, now owned and hereafter created or acquired, and if we default on those obligations, the holder could foreclose on our bank and securities accounts.
  • Risks Related to Our Operations
  • Difficulty in qualifying a contract manufacturer, Tier 1 partner, or foundry for our products, or experiencing challenges in our supply chain, could cause delays that may result in lost future revenues and damaged customer relationships.
  • Historically, we have been dependent on third parties to develop, manufacture, sell and market products incorporating our technology.
  • We could face lawsuits related to our use of our core technologies, which would be costly, and any adverse outcome could limit our ability to commercialize our technologies or products.
  • If we fail to manage expansion effectively, our revenue and expenses could be adversely affected.
  • We target customers that are large companies with substantial negotiating power and potentially competitive internal solutions; if we are unable to sell our products to these customers, our prospects will be adversely affected.
  • Our technology and products may be subject to environmental, health and safety regulations that could increase our development and production costs.
  • Our operating results may be adversely impacted by worldwide political and economic uncertainties and specific conditions in the markets we address.
  • Because a significant proportion of our company is outside of the U.S. and we utilize foreign suppliers and manufacturers, our operating results could be harmed by economic, political, regulatory and other factors in foreign countries.
  • We have recently made and may in the future make acquisitions. If we fail to successfully select, execute or integrate our acquisitions, then our business, results of operations and financial condition could be materially adversely affected.
  • Our suppliers’ or manufacturing partners’ facilities could be damaged or disrupted by a natural disaster or labor strike, either of which would materially affect our financial position, results of operations and cash flows.
  • If we are unable to obtain effective intellectual property protection for our products, processes and technologies, we may be unable to compete with other companies.
  • We could be subject to significant product liability claims that could be time consuming and costly, divert management attention and adversely affect our ability to obtain and maintain insurance coverage.
  • Our operations could be adversely impacted by information technology system failures, network disruptions, or cybersecurity incidents.
  • Loss of any of our key personnel or inability to attract new personnel could have a negative effect on the operation of our business.
  • We are exposed to risks related to the use of AI tools by us and others.
  • Risks Related to Development for our Target Markets
  • We invest significant time and resources seeking OEM selection of our products and solutions. If our products and solutions are not selected for inclusion in ADAS systems by automotive OEMs or automotive Tier 1 suppliers after incurring substantial expenditures in these efforts, our future business prospects, results of operations, and financial condition will be materially and adversely affected.
  • The complexity of our products and the limited visibility into the various environmental and other conditions under which potential customers may use the products could result in unforeseen delays or expenses from undetected defects, errors or reliability issues in hardware or software which could reduce the market adoption of our products, damage our reputation with prospective customers, expose us to product liability and other claims, and adversely affect our operating costs.
  • Adverse conditions in particular industrial sectors, the automotive industry, or the global economy more generally could have adverse effects on our results of operations.
  • Developments in alternative technology may adversely affect the demand for our lidar technology.
  • ADAS features may be delayed in adoption by OEMs, which would negatively impact our long-term business prospects.
  • Because the lidar and ADAS markets are rapidly evolving, it is difficult to forecast customer adoption rates, demand, and selling prices for our products and solutions.
  • Because perception solutions involving lidar are new in the markets we are seeking to enter, opportunities in those market and related forecasts may not materialize as anticipated.

Legal proceedings

We are subject to various claims and pending or threatened lawsuits in the normal course of business. We are not currently party to any other legal proceedings that management believes are reasonably possible to have a material adverse effect on our financial position, results of operations or cash flows.

The opening of Item 3, Legal Proceedings.7

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
    Company websiteMicroVision, Inc. logo
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54
  55. 55
  56. 56
  57. 57
  58. 58
  59. 59
  60. 60
  61. 61
  62. 62
  63. 63
  64. 64
  65. 65
  66. 66
  67. 67
  68. 68
  69. 69
  70. 70
  71. 71
    SEC EDGAROther events
  72. 72
  73. 73
  74. 74
  75. 75
  76. 76
  77. 77
  78. 78
  79. 79
  80. 80
  81. 81
    SEC EDGAROther events
  82. 82
  83. 83
  84. 84
  85. 85
  86. 86
  87. 87
  88. 88
  89. 89
  90. 90
  91. 91
  92. 92
  93. 93
  94. 94